Auto Loan Amortization Schedule

Response Oncology, Inc. recently reported record auto loan amortization schedule financial results for the second quarter and six months ended June 30, 2007. For the second quarter 2007, net revenues increased 27.2% to $32,627,000, from the $25,642,000 reported for the second quarter 2006. Net income for the second quarter 2007 increased 17.8% to $1,428,000 from the $1,212,000 reported for the second quarter 2006. Diluted earnings per share increased to $ 0.12 as compared to $ 0.10 reported for the second quarter 2006. Business growth in the second quarter 2007 as compared to second quarter 2006 was driven by substantial increases in all core service lines.

-- Revenues from advanced cancer treatment centers increased 18.5% from the second quarter of 2006 to the second quarter of 2007. This growth was largely driven by a 14% increase in the number of patients treated as compared to the number treated in second quarter 2006. Same location growth in this service line increased 13% between the periods. -- Revenues from oncology practice management services increased 28.9%, with same practice growth at 21.5%. -- Contract clinical trials revenues increased 14.3%, with the backlog increasing from $ 10 million at the end of the first quarter of 2007 to $ 14 million at the end of the second quarter 2007.

The number of patients in clinical trials during the quarter increased 84% as compared to the second quarter 2006. -- Revenues from pharmaceutical sales to affiliating physicians increased 42.2%, which is partially a reflection of the more extensive use of newer, thus more expensive drugs.

As of June 30, 2007, the Company has added radiation oncology and diagnostic imaging to its South Florida market. This is in keeping with Response's objectives of providing a full range of oncology services on a local basis and capturing a larger share of the revenue per patient or per case. The ancillary service agreements with the physician practices generally call for a fifty percent split in operating income between the practices and the Company. For the six months ended June 30, 2007, net revenues increased 24.4% to $ 62,222,000, from $ 50,007,000 for the same period in 1997. Net income increased 30.8% to 2,720,000, or $ 0.22 per diluted share, from the $ 2,079,000, 0r $ 0.19 per diluted share reported for the first six months of 2006.

In commenting on these results, Dr. William West, Chairman, said, "We are very pleased with the results of our second quarter and the continuing improvement in revenue and profitability. The strong positive comparisons in the quarter largely reflected our same market growth and are a very positive indication that our unique business model is effective.

While we continue to pursue physician practice acquisitions and IMPACT Center development opportunities, we believe that profitable same market growth will be well-served by the addition of ancillary services and new or incremental third party contracts to our networks. The quality of care delivered by our affiliated physicians and the increasing range of services to be delivered under our umbrella has been key to our increasing market penetration."